PRVA

In the past six months, Privia Health Group, Inc. reported its Fourth Quarter and Full-Year 2025 financial results on February 26, 2026, which included beating revenue and EPS expectations. The First Quarter 2026 financial results reported on May 7, 2026, where the company again beat Wall Street's revenue expectations with a 25.8% year-on-year growth, though adjusted EPS missed analyst estimates. Insider trading activity has also been noted, with multiple insider share sales reported in early May 2026. The stock has experienced volatility, with a 3.5% decline over the 7 days leading up to May 9, 2026, but a 7.2% gain over the preceding 30 days, and a year-to-date return of 2.3% against a 4.3% loss over the past year. The stock's negative reaction to the Q1 2026 earnings reflected investor disappointment that operational improvements had not yet translated to bottom-line profitability as expected.